Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises 6 Dimensions and Its Portfolio Ignis Therapeutics on Ignis’ $180 Million Series A Financing and Strategic Licensing Agreement with SKBP

  • 11/14/21
  • Client Highlights
  • Life Sciences
  • Biotech

Copyright © 2021 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.